Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

David R Tribble, MD, DrPH (240) 694-2948
david.tribble@usuhs.edu


Tahaniyat Lalani, MD (240)694-2948
tlalani@idcrp.org


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel
Back

Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel

Recruiting

Open to: ALL

Age: 18.0 - 70.0

Birmingham Liverpool

Medical Conditions

Diarrhea

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Passive immunoprophylaxis is a class of dietary supplements that is lawfully marketed in the US for maintenance of gut health (GH). This randomized, double-blind, clinical trial will evaluate passive immunoprophylaxis (Travelan®) product compared with placebo, to assess the ability to maintain normal gut function during travel. The results of this clinical trial will be used to evaluate the use of a dietary supplement to maintain GH during deployment and travel and is not intended to support a marketing application of any dietary supplement as a drug or biological product for human use.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

May 2022 Jul 2025

INTERVENTIONAL

Intervention Type : DIETARY_SUPPLEMENT
Intervention Description : Travelan® (600mg) taken as 1 sachet twice daily with meals. Product will be started 2 days prior to arrival and maintained for a maximum duration of 20 days (minimum of 10 days) during travel or deployment.

Intervention Arm Group : Travelan®;

Intervention Type : OTHER
Intervention Description : Maltodextrin - To be started 2 days prior to arrival and maintained for a maximum duration of 20 days (minimum of 10 days) during travel or deployment.

Intervention Arm Group : Placebo;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • United Kingdom Ministry of Defence
    Birmingham
  • The Liverpool School of Tropical Medicine- Well Travelled Clinic
    Liverpool

David R Tribble, MD, DrPH (240) 694-2948
david.tribble@usuhs.edu


Tahaniyat Lalani, MD (240)694-2948
tlalani@idcrp.org



The study is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine and is in collaboration with Uniformed Services University of the Health Sciences.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT04605783
Last updated 18 March 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top